Physician profile
Aaron Webb
NPI 1013465681
$780.60
in general payments reported to CMS, 2019-2025
11 companies · $25.22 in 2025
The $25.22 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $440 · 2022: $256 · 2023: $39.54 · 2024: $19.76 · 2025: $25.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $177.14 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $163.40 | 2021-2022 | |
| Glaxosmithkline, LLC. | $137.52 | 2022 | |
| Lilly USA, LLC | $76.21 | 2021-2022 | |
| Abbott Laboratories | $75.26 | 2022-2023 | Amplatzer Piccolo, Freestyle Libre 3 |
| Boston Scientific Corporation | $44.98 | 2024-2025 | General - Pain Management |
| Pfizer INC. | $34.96 | 2021-2022 | |
| Abbvie INC. | $22.99 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.07 | 2021 | |
| Pbg Puerto Rico LLC | $15.64 | 2021 | |
| Amarin Pharma, INC. | $13.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.